Gambia vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Gambia rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Western Pacific (WHO region)
How they compare
Gambia currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Gambia's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 4 times across 16 shared years of data; in 2006 it was Gambia ahead.
Gambia ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Across the 3 decades both report, Gambia averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Gambia | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.8% | 1.1% | 51.7% | Gambia |
| 2010s | 53.6% | 65.1% | 11.6% | Western Pacific (WHO region) |
| 2020s | 89.4% | 89.2% | 0.2% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Western Pacific (WHO region)?
- Gambia, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Western Pacific (WHO region)?
- 14.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Western Pacific (WHO region)?
- 16 years are reported by both, from 2006 to 2024.
- How do Gambia and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.